Home > Insider Trading > Epirus Biopharmaceuticals Inc. > Profile

Epirus Biopharmaceuticals Inc. (EPRS)

Market is closed

Sector: Pharmaceutical Preparations

Related Insiders

A. Thomas Shea, Chief Financial Officer, 2016-05-31
Michael Wyand, President And Coo, 2016-05-31
Vincent Aurentz, Chief Business Officer, 2016-05-31

A. Thomas Shea, Chief Financial Officer, 2016-05-31
Michael Wyand, President And Coo, 2016-05-31
Vincent Aurentz, Chief Business Officer, 2016-05-31
Robert Ticktin, General Counsel, 2016-05-31
Amit Munshi, Chief Executive Officer, 2016-03-01
M Scott Rocklage, Large Shareholder, Director, 2015-06-08
Julie Mchugh, Director, 2015-06-08
L William Hunter, Director, 2015-06-08
Daotian Fu, Director, 2015-06-08
M Geoffrey Duyk, Director, 2015-06-08
Mark Corrigan, Director, 2015-06-08
Kevin J Buchi, Director, 2015-06-08
Montreux Equity Partners Iv Lp, Large Shareholder, 2015-02-09
Montreux Equity Partners V, L.p., Large Shareholder, 2015-02-09
J. Andrew Schwab, Large Shareholder, 2015-02-06
5Am Partners Iii, Llc, Large Shareholder, 2015-02-06
5Am Co-Investors Iii, L.p., Large Shareholder, 2015-02-06
5Am Ventures Iii, L.p., Large Shareholder, 2015-02-06
D John Diekman, Large Shareholder, 2015-02-06
Livzon Mabpharm Inc., Large Shareholder, 2014-08-04
Kim Seth, Chief Business Officer, 2014-07-18
David Bonderman, Large Shareholder, 2014-07-17
G James Coulter, Large Shareholder, 2014-07-17
Tpg Group Holdings (Sbs) Advisors, Inc., Large Shareholder, 2014-07-17
A Justin Renz, Evp, Cfo & Treasurer, 2014-02-12
J William Oshea, Director, 2013-06-10
Michael Kauffman, Director, 2013-06-10
Frank Haydu, Director, 2013-06-10
Sally Crawford, Director, 2013-06-10
Jason Cole, Evp,Corp Dev & General Counsel, 2013-01-07
Todd Foley, Director, 2012-05-25
C. Christopher Gallen, Evp Research & Development, 2012-02-29
Iii J Nicholas Simon, Large Shareholder, 2011-10-28
Ansbert Gadicke, Large Shareholder, 2011-10-28
Luke Evnin, Large Shareholder, 2011-10-28
Kurt Wheeler, Large Shareholder, 2011-10-28
Nicholas Galakatos, Large Shareholder, 2011-10-28
Dennis Henner, Large Shareholder, 2011-10-28
Michael Steinmetz, Large Shareholder, 2011-10-28
L.p. Iii Bioventures Mpm, Large Shareholder, 2011-10-28
L.p. Iii-Qp Bioventures Mpm, Large Shareholder, 2011-10-28
Mpm Asset Management Llc, Large Shareholder, 2011-10-28
Mpm Bioventures Iii Llc, Large Shareholder, 2011-10-28
L.p. Gp Iii Bioventures Mpm, Large Shareholder, 2011-10-28
Mpm Asset Management Investors 2003 Bviii Llc, Large Shareholder, 2011-10-28
Mpm Bioventures Iii Gmbh & Co. Beteiligungs Kg, Large Shareholder, 2011-10-28
Mpm Bioventures Iii Parallel Fund, L.p., Large Shareholder, 2011-10-28
T Hartley Richardson, Director, 2011-05-26
P. Terrance Snutch, Svp & Chief Scientific Officer, 2010-03-03
Eugene C. Wright, Svp & Chief Dev Officer, 2010-03-03
Biotechnolo P L Fund Value Biotechnology P/Il L Partners Bvf, Large Shareholder, 2009-12-24
Robert Forrester, Officer, 2009-01-28
Alexis Borisy, Officer, Director, 2009-01-28

Show All Insiders (53)

Hedge Fund Popularity

Display

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on November 14, 2016, 10:29 pm based on SEC 13F filings Last update: November 14, 2016, 10:29 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Camber Capital Management Stephen Dubois	0	$0		0%
2.	Adage Capital Management Phill Gross And Robert Atchinson	0	$0		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Ticktin	$3.72	3,000	Officer	3,000	2015-12-21	Filing
Vincent	$3.43	2,200	Officer	2,200	2015-12-17	Filing
Munshi	$2.80	8,270	Officer, Director	169,982	2015-12-16	Filing
Munshi	$2.87	8,069	Officer, Director	161,712	2015-12-15	Filing
Vincent	$3.85	2,800	Officer	2,800	2015-12-09	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Montreux	$5.01	100,000	Large Shareholder	1,671,400	2015-02-06	Filing
Montreux	$4.97	67,316	Large Shareholder	1,771,400	2015-02-05	Filing
Montreux	$4.95	5,684	Large Shareholder	1,838,716	2015-02-04	Filing
Montreux	$4.99	47,000	Large Shareholder	1,844,400	2015-02-03	Filing
Montreux	$6.47	38,516	Large Shareholder	1,891,400	2015-01-26	Filing